Global Coronary Artery Disease Treatment Devices Market Size By Type (Coronary Stents, PTCA Balloon Catheters), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Coronary Artery Disease (CAD) Treatment Devices Market was valued at USD 16.1 billion in 2023 and is projected to reach USD 26.9 billion by 2031, growing at a CAGR of 6.6% during the forecast period from 2023 to 2031. The market growth is driven by the increasing prevalence of cardiovascular diseases, technological advancements in interventional cardiology, and rising awareness about minimally invasive procedures. The demand for coronary stents, balloon catheters, and other CAD treatment devices is accelerating, fueled by lifestyle-induced risk factors such as obesity, smoking, hypertension, and diabetes.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases:

Globally, coronary artery disease remains one of the leading causes of mortality. With increasing aging populations and sedentary lifestyles, the demand for effective treatment devices is rising steadily.

2. Technological Innovations in Treatment Devices:

New-generation drug-eluting stents, bioresorbable vascular scaffolds, and advanced balloon catheters are significantly enhancing treatment efficacy and patient outcomes, propelling market adoption.

3. Increasing Demand for Minimally Invasive Procedures:

Patients and healthcare providers are gravitating towards minimally invasive options due to shorter hospital stays, reduced procedural risks, and faster recovery.

Restraints:

1. High Cost of Advanced CAD Devices:

Premium pricing for cutting-edge devices, especially in emerging economies, limits widespread access to these technologies, acting as a growth barrier.

2. Product Recalls and Regulatory Challenges:

Frequent recalls and stringent regulatory pathways for device approval can delay market entry and diminish consumer confidence.

Opportunity:

1. Expanding Healthcare Infrastructure in Emerging Economies:

Countries like India, China, and Brazil are rapidly improving their cardiac care facilities. This growth in healthcare infrastructure opens lucrative avenues for device manufacturers.

2. Focus on Personalized and AI-Assisted Treatment Planning:

The integration of artificial intelligence and real-time imaging with CAD devices is enabling more precise and customized interventions, paving the way for innovation-led growth.

Market by System Type Insights:

Based on system type, the Drug-Eluting Stents (DES) segment accounted for the largest market share in 2023. DES offers superior outcomes in preventing restenosis compared to bare-metal stents, leading to widespread adoption. The Bioresorbable Vascular Scaffold (BVS) segment is expected to grow significantly, driven by ongoing R&D and growing preference for next-generation, fully absorbable solutions.

Market by End-use Insights:

In terms of end-use, Hospitals and Cardiac Centers dominated the market in 2023, holding over 65% of the share. These settings are equipped with advanced technologies and trained personnel, making them the preferred choice for complex interventions. Ambulatory Surgical Centers (ASCs) are witnessing growing adoption due to their cost-effectiveness and convenience for patients requiring less complex procedures.

Market by Regional Insights:

North America held the largest share of the CAD treatment devices market in 2023, driven by high healthcare spending, favorable reimbursement policies, and early technology adoption. However, the Asia-Pacific region is expected to experience the fastest growth during the forecast period, supported by a rising patient population, government health initiatives, and increasing access to quality cardiac care in developing countries.

Competitive Scenario:

Leading players in the Global Coronary Artery Disease Treatment Devices Market include:

Medtronic plc

Abbott Laboratories

Boston Scientific Corporation

Terumo Corporation

Biotronik SE & Co. KG

B. Braun Melsungen AG

Cardinal Health, Inc.

Koninklijke Philips N.V.

GE Healthcare

Biosensors International Group, Ltd.

These companies are actively engaged in new product launches, strategic collaborations, and geographic expansion. For example:

In 2023, Abbott Laboratories launched a next-generation drug-eluting stent with enhanced deliverability and safety profile.

In 2024, Boston Scientific expanded its coronary intervention portfolio by acquiring a startup specializing in AI-guided imaging for real-time stent placement optimization.

Scope of Work – Global Coronary Artery Disease Treatment Devices Market

Report Metric Details

Market Size (2023) USD 16.1 billion

Projected Market Size (2031) USD 26.9 billion

CAGR (2023–2031) 6.6%

Market Segments By System Type, By End-Use, By Region

Growth Drivers Increasing CAD prevalence, technology advancements, demand for minimally invasive procedures

Opportunities Growth in emerging markets, AI and personalized interventions

Key Market Developments:

March 2023: Medtronic received CE Mark approval for its novel sirolimus-eluting stent designed to optimize endothelial healing.

June 2024: Terumo introduced an ultra-low profile balloon catheter aimed at complex and tortuous vascular interventions.

January 2025: Biotronik announced a collaboration with a leading AI software provider to integrate predictive modeling in post-procedure patient monitoring.

FAQs:

1) What is the current market size of the Global Coronary Artery Disease Treatment Devices Market?

The market was valued at USD 16.1 billion in 2023.

2) What is the major growth driver of the Global Coronary Artery Disease Treatment Devices Market?

The major growth driver is the increasing global burden of cardiovascular diseases and the growing preference for minimally invasive treatments.

3) Which is the largest region during the forecast period in the Global Coronary Artery Disease Treatment Devices Market?

North America held the largest market share in 2023, while Asia-Pacific is expected to register the highest growth rate through 2031.

4) Which segment accounted for the largest market share in Global Coronary Artery Disease Treatment Devices Market?

The Drug-Eluting Stents (DES) segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Coronary Artery Disease Treatment Devices Market?

Key players include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, and Biotronik SE & Co. KG.